Antiproliferative

"Anti-proliferative" is not the name of a specific molecular target or receptor. Instead, it refers to any substance—typically a drug or compound—that inhibits or prevents the proliferation and rapid growth of cells. This term is most commonly used in oncology to describe agents that block tumor cell division by interfering with various stages of the cell cycle or inducing programmed cell death. Examples include DNA-damaging agents, cyclin-dependent kinase inhibitors that arrest interphase progression,[2] anti-mitotic drugs that disrupt mitosis,[8] and microtubule-targeting compounds such as paclitaxel.[8] The term can also apply more broadly to any context where limiting unwanted cellular proliferation is desired—for example in preventing vascular smooth muscle overgrowth after angioplasty.[1] Because "anti-proliferative" describes an effect rather than a discrete biological entity or therapeutic target molecule/receptor/protein/gene/family/complex/pathway/etc., it should not be treated as a canonical molecular target for structured data purposes. In summary: "Anti-proliferative" does not refer to an individual molecule/receptor/target but rather describes an activity shared by many different classes of therapeutic agents. It should not be considered a valid entry for structured molecular targeting information. There is no universal biomarker for "antiproliferative" as it is not a specific target. Safety concerns depend on the specific antiproliferative agent used.

Other names

Anti-proliferativeAntiproliferative agentAntiproliferative drug

Mechanisms vary by drug class; may include DNA damage, inhibition of mitosis/microtubules, kinase inhibition[2][6]